Two abstracts for the EASL Congress 2024 from Hannes Hagstrom’s team leads the group to focus on the future of Big Data within MASLD diagnosis and therapies.
This conversation starts when co-host Jörn Schattenberg joins our EASL Congress 20224 preview. The episode itself focuses on the future of hepatology along with other MASLD abstracts and presentations.
This conversation centers around two thoughts about the EASL Congress 2024 from Michelle Long.one on network value and the other on the reat benefit that comes from reviewing abstracts in advance.
EASL Secretary General Aleksander Krag offers his vision for the EASL Congress 2024, after which Hannes Hagstrom shared some impressions.
EASL Secretary General Aleksander Krag and our other guests, Hannes Hagstrom and Michelle Long, join Jörn Schattenberg and Roger Green to discuss MASLD-related highlights of EASL Congress 2024.
This week’s vault episode offers the last time Stephen Harrison presented results of a specific drug trial on the podcast.
This second conversation with Dimitar Tonev and Roger Green focus on some of the elements of Stephen’s personality that made him a role model for the entire community in Dimitar’s eyes.
Jörn Schattenberg, Donna Cryer and Roger Green continue their conversation of Stephen Harrison by discussing his consistent efforts to be sure the voices of patients and allied health providers were included in key conversations.
Donna Cryer, Jörn Schatenberg and Roger Green reflect on Stephen Harrison’s ability to bring together all the various elements of the MASLD community in pursuit of knowledge and a first approved drug.
In two separate conversations, Global Liver Institute Founder and CEO and industry executive and consultant hepatologist Dimitar Tonev share memories of Stephen Harrison with co-hosts Jörn Schattenberg and Roger Green.
